abstract |
The present invention relates to a use of an NMDA receptor or an AMPA receptor antagonist for the preparation of a medicament for preventing, treating, inhibiting or delaying a disease which is overactivated by an NMDA receptor or an AMPA receptor, wherein the NMDA receptor antagonist is selected From the group consisting of Paeonol, Baicalein, Rutin, Ginkgolide A, and combinations thereof, and the AMPA receptor antagonist is Baicalein. . |